Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive chemotherapy. As medulloblastoma exhibits marked intertumoural heterogeneity, with at least four distinct molecular variants, previous attempts to identify targets for therapy have been underpowered because of small samples sizes. Here we report somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastomas. SCNAs are common in medulloblastoma, and are predominantly subgroup-enriched. The most common region of focal copy number gain is a tandem duplication of SNCAIP, a gene associated with Parkinson's disease, which is exquisitely restricted to Group ...
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children. Despite recent imp...
Medulloblastomas and related primitive neuroectodermal tumors are the second most common malignant t...
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterog...
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspe...
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspe...
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitatin...
Medulloblastoma is the most common malignant brain tumor in children. In recent years, there has bee...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. ...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in...
Medulloblastomas are the most common malignant brain tumours in children. Identifying and understand...
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterog...
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children. Despite recent imp...
Medulloblastomas and related primitive neuroectodermal tumors are the second most common malignant t...
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterog...
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspe...
Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspe...
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitatin...
Medulloblastoma is the most common malignant brain tumor in children. In recent years, there has bee...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. ...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in...
Medulloblastomas are the most common malignant brain tumours in children. Identifying and understand...
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterog...
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children. Despite recent imp...
Medulloblastomas and related primitive neuroectodermal tumors are the second most common malignant t...
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterog...